Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -44.44%

Guardant Health, Inc. EBITDA Margin is -44.44% for the Trailing 12 Months (TTM) ending June 30, 2025, a -35.61% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -69.02%, a -23.99% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -90.81%, a -26.15% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -122.95%, a 15.84% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -106.14%, a 179.86% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin